FDA Drug Application (202513) for GELNIQUE 3% by ALLERGAN SALES LLC

Back to FDA Applications sponsored by ALLERGAN SALES LLC

Application Number202513
Product Number001
FormGEL, METERED;TRANSDERMAL
Dosage3%
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameGELNIQUE 3%
Active IngredientOXYBUTYNIN

Active IngredientCount
List of drugs with Active Ingredient OXYBUTYNIN4


Back to FDA Applications sponsored by ALLERGAN SALES LLC